Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
about
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasionThe emerging role of the LIV-1 subfamily of zinc transporters in breast cancerMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerEpigenetic regulation in estrogen receptor positive breast cancer--role in treatment responseSrc tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemiaPaxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionExpression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.Pathways to tamoxifen resistance.Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer.Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancerBreast cancer patients' clinical outcome measures are associated with Src kinase family member expression.Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cellsGlobal characterization of signalling networks associated with tamoxifen resistance in breast cancer.Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinaseSRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatmentLYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancerc-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formationPhase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanomaAcquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin aCytoplasmic estrogen receptor in breast cancer.Bone Targeted Therapies for Bone Metastasis in Breast CancerAnti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistanceCombined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.Triple-negative breast cancer: are we making headway at least?Src-signaling interference impairs the dissemination of blood-borne tumor cellsProtein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancerProteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
P2860
Q24294568-8C917584-F176-451A-98C8-27C78C9B8A92Q24317461-F2800EB0-1896-4C63-8BCD-2ECDAC29106FQ24682854-1AA78EE6-028A-45FC-963B-5ED0E2103947Q26775086-26C5210D-A50F-4759-B4EC-0C21AF8DA69CQ27694612-E861BBFD-764B-4137-AC6F-BAE4EA655F2AQ28258632-8A605AE2-A746-4A90-A165-12217DF8F44CQ28263339-7BD01685-5263-4656-9962-09BE815F0B6CQ30409213-55BD0F29-7BAB-4A54-90B4-3E4973A71DABQ30440238-57C6C3AC-4FDE-4E0F-BBBD-7454788CE79FQ30441001-7ECFB93C-FFB5-44E1-9D9F-FB1343C91E17Q30679405-9CE1AE43-F9A4-462E-9727-81298D747448Q33530940-7BDBA66C-7B11-4C4A-A17F-0B4FB180A478Q33624824-0CF3CC1F-FD8A-4531-B694-14DC88548452Q33808203-0DC5EE67-AC38-4894-8D3B-3FA24296593FQ33992390-A1A5C6D6-8798-4505-8930-243BCDD52324Q34018570-9B3FBBB6-2133-4D95-A1AB-014C0F160408Q34100838-B7924CC5-FE3C-4812-9843-26DB3E9D1D2BQ34211720-20560944-EE20-48E0-BE69-AB0E4D87E696Q34253693-6969EADE-77A7-4DAD-B31B-A78592DC9896Q34693000-2F364637-1D0A-4FF9-A983-1F97293176D6Q34857146-F5E416BA-0E0A-4925-B9F7-E34356657615Q34959208-22E0BB6B-06F7-4C2E-963A-0739D10CC34FQ35094072-4C9BBB5F-4BB0-4213-B341-574190AF6173Q35113027-8D9C161C-0558-4E2D-AD95-A37E9041F5FFQ35145443-98F05D57-4F4F-473C-ABF7-28E397456153Q35159468-FDC8382B-5E7A-4B40-B8B1-631B0AA975E2Q35569694-2BAFBC62-C268-40D5-ADCB-C43BF7006AE7Q35608736-49D21D33-3005-4BB6-8427-3F7739B0F5CDQ35653813-8D96753E-D9F6-4D77-85FE-F20B3960A04BQ35676447-319A1B73-C960-46E2-B0CB-294001304FC5Q35686728-3D954616-5CA6-41F6-908C-A4F90FA0910BQ35750448-E6AAE9C8-980F-4F72-8661-474C4EC470FAQ35760937-2B708EFD-79A0-4042-A7FB-A6DD82F456EFQ35795153-C97AD0E8-CD14-453C-8D92-C2AF8F701212Q35982097-971CC939-7016-4961-A2CB-39CAD1789C71Q36053869-12B15D8F-F06D-416F-A6E5-429B6B2B190AQ36061177-B5475B7E-7A8E-4C8A-BDE9-66C934B35902Q36153123-37596FFF-57FB-4A00-AC70-4F319735FB4EQ36172210-EF259461-FA16-4515-8A88-234A17E82C73Q36245528-0B1A85AF-1917-45F8-84B0-76E56BB23718
P2860
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Elevated Src activity promotes ...... resistant breast cancer cells.
@en
type
label
Elevated Src activity promotes ...... resistant breast cancer cells.
@en
prefLabel
Elevated Src activity promotes ...... resistant breast cancer cells.
@en
P2093
P2860
P50
P1476
Elevated Src activity promotes ...... resistant breast cancer cells
@en
P2093
Denise Barrow
Robert I Nicholson
Tim P Green
P2860
P2888
P304
P356
10.1007/S10549-005-9120-9
P407
P577
2005-12-07T00:00:00Z
P6179
1037552899